2018 International Congress » Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)
Date: Sunday, October 7, 2018
Time: 1:45pm-3:15pm
Location: Hall 3FG
Meeting: 2018 International Congress
- 1:45pm-3:15pm
-
18F-FDG PET brain in Parkinsonism
- 1:45pm-3:15pm
-
A longitudinal study of brain quantitative MRI analysis before and after diagnosis of progressive supranuclear palsy
- 1:45pm-3:15pm
-
A panel of CSF and plasma biomarkers reveals novel biological insights into atypical parkinsonian syndromes
- 1:45pm-3:15pm
-
A Young Man with Multiple System Atrophy: A Case Report
- 1:45pm-3:15pm
-
Amyotrophic Lateral Sclerosis-Progressive Supranuclear Palsy Phenotype with Negative C9ORF72 Mutation
- 1:45pm-3:15pm
-
An atutopsy case of argyrophilic grain disease, clinically presenting with Parkinson dementia
- 1:45pm-3:15pm
-
Apolipoprotein E and multiple system atrophy
- 1:45pm-3:15pm
-
Association of impaired melatonin secretion with sleep disturbance in multiple system atrophy
- 1:45pm-3:15pm
-
Background pathology of ‘corticobasal degeneration (CBD) mimics’ -Japanese validation study of CBD (J-VAC study)
- 1:45pm-3:15pm
-
Cerebellar signs in progressive supranuclear palsy
- 1:45pm-3:15pm
-
Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)
- 1:45pm-3:15pm
-
Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes
- 1:45pm-3:15pm
-
Corticobasal Syndrome: A Single Center Case Series
- 1:45pm-3:15pm
-
Deep brain stimulation in a patient with Spinocerebellar ataxia type 2 presenting as Parkinson’s disease: A case report
- 1:45pm-3:15pm
-
Diffusion magnetic resonance imaging for predicting the severity of Progressive supranuclear palsy
- 1:45pm-3:15pm
-
Disease progression and survival of multiple system atrophy: A prospective French cohort study
- 1:45pm-3:15pm
-
Evolution of diagnostic certainty and PSP-predominance types in 187 pathologically confirmed PSP patients
- 1:45pm-3:15pm
-
Immunological causes of atypical parkinsonism
- 1:45pm-3:15pm
-
Influence of Wearing Empty Backpack on Gait and Balance in Patients with Degenerative Parkinsonian syndrome
- 1:45pm-3:15pm
-
Midbrain Diameter Measurements on High-Resolution Computer Tomography Scans to aid diagnosis of Progressive Supranuclear Palsy
- 1:45pm-3:15pm
-
Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies
- 1:45pm-3:15pm
-
MRI volumetrics in parkinsonian syndromes
- 1:45pm-3:15pm
-
MSA Preliminary Panamerican Report
- 1:45pm-3:15pm
-
Non-motor symptoms in patients from the Catalonian Multiple System Atrophy Registry (CMSAR)
- 1:45pm-3:15pm
-
Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?
- 1:45pm-3:15pm
-
Olfactory testing in Parkinson plus syndromes
- 1:45pm-3:15pm
-
Patient Perspective in Multiple System Atrophy
- 1:45pm-3:15pm
-
Prevalence of REM sleep behavior disorder and sleep-disordered breathing in multiple system atrophy: A meta-analysis
- 1:45pm-3:15pm
-
Probable MSA presenting initially with urinary retention
- 1:45pm-3:15pm
-
Progressive Supranuclear Palsy and Eye of the Tiger Sign
- 1:45pm-3:15pm
-
Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy
- 1:45pm-3:15pm
-
Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy
- 1:45pm-3:15pm
-
Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults
- 1:45pm-3:15pm
-
Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report
- 1:45pm-3:15pm
-
Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study
- 1:45pm-3:15pm
-
Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome
- 1:45pm-3:15pm
-
Serum cholesterol level is associated with risk of MSA
- 1:45pm-3:15pm
-
Spatial correlation and segregation of multimodal MRI abnormalities in multiple system atrophy
- 1:45pm-3:15pm
-
The clinical spectrum of motor stereotypies in progressive supranuclear palsy: An early, frequent and underestimated symptom
- 1:45pm-3:15pm
-
The role of deep brain stimulation targeting GPi in patients with multiple system atrophy
- 1:45pm-3:15pm
-
The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
- 1:45pm-3:15pm
-
The Timed Up & Go test (time) is inversely associated with fall frequency in progressive supranuclear palsy
- 1:45pm-3:15pm
-
Toxin-induced Parkinsonism: A report of two patients